AMPWP
GSK icon

Alvarez & Marsal Private Wealth Partners’s GSK GSK Stock Holding History

Alvarez & Marsal Private Wealth Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,465
Closed -$416K – 144
2026
Q1 		$416K Buy
+7,465
New +$405K 0.06% 93

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Alvarez & Marsal Private Wealth Partners's GSK Position: Q2 2026 in Review

Alvarez & Marsal Private Wealth Partners sold out of GSK (GSK) in Q2 2026, closing a stake of 7,465 shares — an estimated $416K sold.

Alvarez & Marsal Private Wealth Partners first reported a position in GSK in Q1 2026 and held it in 1 quarter. The position peaked at $416K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Alvarez & Marsal Private Wealth Partners reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • Alvarez & Marsal Private Wealth Partners sold 7,465 GSK shares in Q2 2026, an estimated $416K.
  • Alvarez & Marsal Private Wealth Partners first reported a position in GSK in Q1 2026 and held it in 1 quarter.
  • Alvarez & Marsal Private Wealth Partners's GSK position peaked at $416K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Alvarez & Marsal Private Wealth Partners's 13F filing for Q2 2026, filed 14 Aug 2026.